ArticleCancer reports (Hoboken, N.J.)2026

Successful Management of Suspected Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in BRAF-Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report.

Akira Shibata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.